![](/img/cover-not-exists.png)
Prognostic and predictive factors in a randomized phase III trial comparing cisplatin-pemetrexed versus cisplatin-gemcitabine in advanced non-small-cell lung cancer
Syrigos, K. N., Vansteenkiste, J., Parikh, P., von Pawel, J., Manegold, C., Martins, R. G., Simms, L., Sugarman, K. P., Visseren-Grul, C., Scagliotti, G. V.Volume:
21
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdp392
Date:
March, 2010
File:
PDF, 94 KB
english, 2010